NCT02522767 Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) Status COMPLETED Phase PHASE3
NCT02520284 Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2/PHASE3
NCT02516384 Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) Status COMPLETED Phase PHASE1
NCT02508012 Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02506179 Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis Status COMPLETED Phase N/A
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort Status COMPLETED Phase N/A
NCT02499263 A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice Status COMPLETED Phase N/A
NCT02488954 Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis Status TERMINATED Phase NA
NCT02487238 Pediatric FEcal Microbiota Transplant for Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT02481687 The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease Status TERMINATED Phase N/A
NCT02469220 Diet Treatment of Patients With Ulcerative Colitis in Remission Status COMPLETED Phase NA
NCT02463045 Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects Status COMPLETED Phase PHASE1
NCT02447302 Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02442960 Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT02442037 Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis Status UNKNOWN Phase PHASE1/PHASE2
NCT02439372 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis Status COMPLETED Phase N/A
NCT02435992 Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE3